EG434676 Inhibitors
EG434676 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the EG434676 molecule, which likely plays a critical role in cellular processes such as signal transduction, enzymatic regulation, or protein-protein interactions. EG434676 is thought to be involved in modulating various biochemical pathways that are essential for maintaining cellular homeostasis and functional integrity. By inhibiting EG434676, these compounds interfere with the molecule's ability to interact with its natural substrates or partners, thereby altering the downstream pathways it regulates. This disruption can lead to significant changes in cellular functions, such as energy metabolism, gene expression, or structural organization, depending on the biological context in which EG434676 operates.
Structurally, EG434676 inhibitors are typically designed to bind to specific functional domains of the molecule, such as its active site or other regions critical for its catalytic or binding activities. These inhibitors may function through competitive inhibition, directly blocking the molecule's active site to prevent substrate interaction, or through non-competitive mechanisms that induce structural changes in EG434676, reducing its functional efficiency. The use of EG434676 inhibitors provides researchers with valuable tools to study how this molecule contributes to the regulation of intricate cellular pathways. By examining the effects of EG434676 inhibition, scientists can gain deeper insights into the molecular mechanisms that control cell signaling, protein stability, or other vital cellular processes. This research contributes to a broader understanding of how specific molecules like EG434676 fit into the complex network of biochemical interactions required for maintaining cellular balance and supporting essential biological functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Steroid biosynthesis inhibitor targeting CYP450 enzymes. Inhibits Scgb1b19 indirectly by blocking the synthesis of steroids, potentially impacting the availability of ligands for Scgb1b19's steroid binding activity in the extracellular region. | ||||||
Metyrapone | 54-36-4 | sc-200597 sc-200597A sc-200597B | 200 mg 500 mg 1 g | $26.00 $57.00 $88.00 | 4 | |
Inhibitor of steroidogenesis, affecting adrenal steroid synthesis. Modulates Scgb1b19 indirectly by disrupting steroid production, potentially influencing the availability of ligands for Scgb1b19's steroid binding activity in the extracellular region. | ||||||
Aminoglutethimide | 125-84-8 | sc-207280 sc-207280A sc-207280B sc-207280C | 1 g 5 g 25 g 100 g | $42.00 $146.00 $541.00 $2060.00 | 2 | |
Aromatase inhibitor impacting estrogen biosynthesis. Alters Scgb1b19 indirectly by disrupting the synthesis of estrogen, which may influence ligand availability for Scgb1b19's steroid binding activity in the extracellular region. | ||||||
Trilostane | 13647-35-3 | sc-208469 sc-208469A | 10 mg 100 mg | $228.00 $1217.00 | 2 | |
Inhibitor of 3-beta-hydroxysteroid dehydrogenase, impacting steroid synthesis. Modulates Scgb1b19 indirectly by interfering with the production of steroids, potentially affecting ligand availability for Scgb1b19's steroid binding activity in the extracellular region. | ||||||
Finasteride | 98319-26-7 | sc-203954 | 50 mg | $105.00 | 3 | |
5-alpha-reductase inhibitor affecting androgen biosynthesis. Alters Scgb1b19 indirectly by disrupting androgen production, potentially influencing the availability of ligands for Scgb1b19's steroid binding activity in the extracellular region. | ||||||
Etomidate | 33125-97-2 | sc-203577 | 10 mg | $126.00 | ||
GABA receptor modulator impacting steroidogenesis. Alters Scgb1b19 indirectly by influencing steroid production, potentially impacting the availability of ligands for Scgb1b19's steroid binding activity in the extracellular region. | ||||||
Exemestane | 107868-30-4 | sc-203045 sc-203045A | 25 mg 100 mg | $134.00 $411.00 | ||
Aromatase inhibitor impacting estrogen biosynthesis. Alters Scgb1b19 indirectly by disrupting estrogen production, potentially influencing ligand availability for Scgb1b19's steroid binding activity in the extracellular region. | ||||||
Abiraterone Acetate | 154229-18-2 | sc-207240 | 5 mg | $231.00 | 1 | |
Selective inhibitor of CYP17 impacting androgen biosynthesis. Inhibits Scgb1b19 indirectly by interfering with androgen production, potentially affecting ligand availability for Scgb1b19's steroid binding activity in the extracellular region. | ||||||
Clotrimazole | 23593-75-1 | sc-3583 sc-3583A | 100 mg 1 g | $42.00 $57.00 | 6 | |
Sterol 14-alpha-demethylase inhibitor affecting ergosterol biosynthesis. Indirectly modulates Scgb1b19 by disrupting sterol synthesis, potentially influencing cellular processes related to steroid binding activity in the extracellular region, and impacting the availability of ligands for Scgb1b19. | ||||||